Corporate Board Profile
Tech Score: 33/100
3 mention(s) identify JEROME B. ZELDIS, MD, PHD as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| SOLIGENIX, INC. | 2021-08-10 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. Dr. Zeldis was selected to serve as a member of our Board of Directors because of his experience as an executive officer of a publicly traded biopharmaceutical company and in clinical research and medical development, and his experience in the health care industry, including his experience as an internist, gastroenterologist and professor of medicine. | Dr. Zeldis holds a PhD in Molecular Biophysics and Biochemistry and has extensive experience in clinical research and medical development, indicating a strong technical background that likely includes programming or related skills. |
| SOLIGENIX, INC. | 2022-08-05 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. | Dr. Zeldis holds a PhD in Molecular Biophysics and Biochemistry, which involves significant scientific and technical expertise that may include programming skills. |
| SOLIGENIX, INC. | 2024-04-29 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. | Dr. Zeldis holds a PhD in Molecular Biophysics and Biochemistry, which is a technical field closely related to software and programming skills, indicating potential capability to write programs. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-05-02 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2017-04-28 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2018-08-10 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2019-07-26 | Jerome B. Zeldis, MD, PhD has been a director since June 2011. ... Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2020-08-07 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2021-08-10 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. Dr. Zeldis was selected to serve as a member of our Board of Directors because of his experience as an executive officer of a publicly traded biopharmaceutical company and in clinical research and medical development, and his experience in the health care industry, including his experience as an internist, gastroenterologist and professor of medicine. |
| 2022-08-05 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2023-08-07 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
| 2024-04-29 | Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. |
Data sourced from SEC filings. Last updated: 2025-07-01